The General Hospital Corporation
Boston, MA Doing business as Massachusetts General Hospital Research Management Part of Partners Healthcare System Incorporated
- UEI
- FLJ7DQKLL226
- CAGE
- 0ULU5
- Primary NAICS
- 622110 General Medical and Surgical Hospitals
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Mass General Brigham Incorporated, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
KH2QJR76KMZ6
-
Parent
KH2QJR76KMZ6
- SAM.gov registration date
- Physical address
- 55 Fruit St, Boston, MA 02114, USA
- Website
- massgeneral.org
- Founded
- 1811
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $5,711,944 |
| FY2025 | $8,823,047 |
| FY2024 | $6,046,783 |
| FY2023 | $23,199,787 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $3,948,736 | |
| 2 | Defense Advanced Research Projects Agency | $1,275,279 | |
| 3 | National Aeronautics and Space Administration | $304,352 | |
| 4 | Department of Veterans Affairs | $143,576 | |
| 5 | Consumer Product Safety Commission | $40,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Children's Research Institute | 75A50124C00035 | $69,962 | |
| Massachusetts Institute Of Technology | 140D042590008 | $496,626 | |
| Children's Research Institute | 75A50124C00035 | $69,962 | |
| Regents Of The University Of Michigan | 75F40124C00131 | $231,024 | |
| President And Fellows Of Harvard College | 75N93019C00071 | $239,623 |
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Mass At Boston | R15CA294070 | $104,376 | |
| University Of Mass At Boston | U01CA279862 | $613,979 | |
| The Johns Hopkins University | U19AI188551 | $627,558 | |
| Regents Of The University Of Michigan | U54DE035412 | $212,880 | |
| The Spaulding Rehabilitation Hospital Corporation | 90DPKT0013 | $37,688 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
The General Hospital Corporation, doing business as Massachusetts General Hospital's Research Management Division, is a nonprofit research and clinical services entity that serves as prime recipient and performer on federal research grants and contracts across the National Institutes of Health, Department of Defense, and specialty agencies—operating as part of Partners Healthcare System. MGH's Research Management Division acts as the prime on 78% of recent awards and competes across full-and-open and non-set-aside mechanisms in health research.
MGH's federal footprint centers on investigator-initiated biomedical research. Recent prime grant work spans fundamental science and translational research: a $3.33 million NHLBI award for cardiovascular disease risk assessment in pregnancy; a $2.4 million heart-lung-blood institute project on cardiovascular mechanisms; a $2 million NINDS cooperative agreement for amyotrophic lateral sclerosis gene therapy clinical research; and an $8.28 million NINDS expanded-access protocol for a TDP-43-targeting therapeutic in ALS. On the federal contract side, MGH holds a $25 million Defense Advanced Research Projects Agency blanket purchase agreement (awarded August 2024, running through August 2027) for commercial accelerators support and DARPA research program services, including clinical evaluations, protocol development, and strategic business support. As of mid-2025, DARPA had issued ten task orders totaling approximately $7.68 million; recent calls ranged from $249 thousand to $3.06 million per order. MGH also performs smaller purchase-order work: a $40 thousand FDA order for allergen potency testing and a $3.58 million NIBIB delivery order for the RADX Innovation Funnel health technologies coordination center.
Customer concentration reflects MGH's orientation toward NIH funding. The National Institutes of Health and its subdivisions account for roughly half of recent award volume across 1,228 prime awards. The National Institute on Aging, National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of Neurological Disorders and Stroke dominate by count; the National Heart, Lung, and Blood Institute and National Institute on Drug Abuse lead by potential dollar value at $80.3 million and $67.5 million respectively. The Department of the Army Medical Command, with $18 million combined potential value across 78 awards, represents the largest non-HHS prime customer. Federal research vehicles include the DARPA BPA (noted above) and multiple NIH indefinite-delivery contracts. The top IDC carries $3.2 million across 65 task orders; a second-tier vehicle anchors $25.7 million across 14 task orders.
Activity has grown over the last five years—523 awards in 2023 to 729 in 2024—but contracted sharply to 432 awards in 2026, suggesting either a timing shift in grant cycles or a change in award recording. Seven hundred forty awards (combined potential value $30.8 million) face ultimate completion within the next twenty-four months, creating significant recompete exposure.
MGH operates as prime on 78% of awards and rarely subcontracts; across SCI-reportable prime contracts, subcontractors accounted for 1% of total contractor hours, with only two named subcontractors identified. This posture suggests MGH performs the majority of contracted work internally. SCI-reportable invoiced revenue totaled $8.8 million across FY2022–FY2025 (FY2024 peak of $5 million), with median government-paid rates around $254/hr and a 90th percentile reaching $663/hr, reflective of senior research and clinical labor. The FTE trajectory across SCI records is volatile—22.1 FTEs in FY2024 contracting to 3.8 in FY2025—suggesting either declining service-contract intensity or a shift toward non-SCI-reportable grant mechanisms.
MGH functions as a sub-recipient on federal grants from Johns Hopkins University (Hepatitis B and HIV Cure Consortium), the University of Michigan (temporomandibular disorder research), and other academic and clinical partners, performing collaborative research ranging from data management and clinical coordination to specialized assays and neuroimaging analysis. The entity also receives federal pass-through funding through state and local organizations, including substance-use treatment awards flowing through the Massachusetts Department of Public Health and Executive Office of Health and Human Services.
No set-aside designations appear in the source award records; MGH competes in the unrestricted federal marketplace. The organization's capability framing in recent federal work emphasizes clinical research infrastructure, biomarker and genomics analysis, neuroimaging, translational therapeutics development, and complex care coordination—anchored in Harvard Medical School affiliation and access to electronic health records spanning Mass General Brigham health systems with over 65,000 genotyped individuals.
Quick answers
Is The General Hospital Corporation registered in SAM.gov?
Yes. The General Hospital Corporation's SAM.gov registration is active through March 20, 2027.
What is The General Hospital Corporation's CAGE code?
The General Hospital Corporation's CAGE code is 0ULU5, and its Unique Entity ID (UEI) is FLJ7DQKLL226.
How much has The General Hospital Corporation received in federal contracts?
Federal contracts obligated $8,823,047 to The General Hospital Corporation in fiscal year 2025 and $43,781,560 in fiscal years 2023 through 2027.
How does The General Hospital Corporation rank among federal contractors?
The General Hospital Corporation's parent company, Mass General Brigham Incorporated, ranked #35 in PSC AR21, #43 in PSC AN12 and #63 in PSC B529 in FY2025.
What is The General Hospital Corporation's most recent federal award?
The General Hospital Corporation's most recent federal grant award is Intestinal fibrosis drives tonic contraction of the aganglionic bowel in hirschsprung disease (F32DK149572), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on January 17, 2027.
On GovTribe
See The General Hospital Corporation's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors